NO20011308D0 - Farmasøytisk preparat som inneholder et syklopeptid og et kjemoterapeutisk middel eller en angiogeneseinhibitor - Google Patents

Farmasøytisk preparat som inneholder et syklopeptid og et kjemoterapeutisk middel eller en angiogeneseinhibitor

Info

Publication number: NO20011308D0
Authority: NO; Norway
Prior art keywords: cyclopeptide; pharmaceutical preparation; chemotherapeutic agent; preparation containing; angiogenesis inhibitor
Prior art date: 1998-09-16

Application number

NO20011308A

Other languages

English (en)

Other versions

NO331734B1 (no

NO20011308L (no

Inventor

Alfred Jonczyk

Astrid Perschl

Simon Goodman

Sigrid Roesener

Jutta Haunschild

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-16

Filing date

2001-03-15

Publication date

2001-03-15

2001-03-15 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2001-03-15 Publication of NO20011308D0 publication Critical patent/NO20011308D0/no

2001-03-15 Publication of NO20011308L publication Critical patent/NO20011308L/no

2012-03-12 Publication of NO331734B1 publication Critical patent/NO331734B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Virology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20011308A 1998-09-16 2001-03-15 Anvendelse av et syklopeptid til fremstilling av et medikament for bekjempelse av tumorer ved stralebehandling. NO331734B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19842415A DE19842415A1 (de)	1998-09-16	1998-09-16	Pharmazeutische Zubereitung
PCT/EP1999/006654 WO2000015244A2 (de)	1998-09-16	1999-09-09	Pharmazeutische zubereitung enthaltend ein cyclo-peptide und ein chemotherapeutikum oder einen angiogeneseinhibitor

Publications (3)

Publication Number	Publication Date
NO20011308D0 true NO20011308D0 (no)	2001-03-15
NO20011308L NO20011308L (no)	2001-03-15
NO331734B1 NO331734B1 (no)	2012-03-12

Family

ID=7881169

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20011308A NO331734B1 (no)	1998-09-16	2001-03-15	Anvendelse av et syklopeptid til fremstilling av et medikament for bekjempelse av tumorer ved stralebehandling.

Country Status (31)

Country	Link
US (1)	US6683051B1 (no)
EP (2)	EP1113809B1 (no)
JP (2)	JP2002524526A (no)
KR (1)	KR100703253B1 (no)
CN (2)	CN1201812C (no)
AR (2)	AR022382A1 (no)
AT (2)	ATE292470T1 (no)
AU (1)	AU765073B2 (no)
BR (1)	BR9913737A (no)
CA (1)	CA2344151A1 (no)
CO (1)	CO5140070A1 (no)
CZ (1)	CZ302908B6 (no)
DE (3)	DE19842415A1 (no)
DK (2)	DK1466615T3 (no)
ES (2)	ES2327331T3 (no)
HU (1)	HUP0103521A3 (no)
ID (1)	ID29226A (no)
IL (2)	IL141516A0 (no)
MY (1)	MY129572A (no)
NO (1)	NO331734B1 (no)
NZ (1)	NZ510040A (no)
PE (1)	PE20001046A1 (no)
PL (1)	PL201902B1 (no)
PT (2)	PT1466615E (no)
RU (1)	RU2227041C2 (no)
SI (1)	SI1113809T1 (no)
SK (1)	SK287012B6 (no)
TR (1)	TR200100765T2 (no)
TW (1)	TW576744B (no)
WO (1)	WO2000015244A2 (no)
ZA (1)	ZA200103073B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7740841B1 (en) *	2000-01-28	2010-06-22	Sunnybrook Health Science Center	Therapeutic method for reducing angiogenesis
PL206142B1 (pl) *	2001-01-09	2010-07-30	Merck Patent Gmbhmerck Patent Gmbh	Kompozycja i zestaw farmaceutyczny do leczenia nowotworów i przerzutów nowotworowych oraz ich zastosowanie
EP1481678A4 (en) *	2002-03-05	2009-12-30	Eisai R&D Man Co Ltd	ANTITUMORAL AGENT CONTAINING A SULFONAMIDE-CONTAINING HETEROCYCLIC COMPOUND AND AN ANGIOGENESIS INHIBITOR
EP1734996B1 (en)	2004-04-02	2013-05-22	The Regents of The University of California	Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
CN104857500A (zh) *	2005-11-02	2015-08-26	杜克大学	同时的化学疗法和免疫疗法
US20110165150A1 (en) *	2006-01-18	2011-07-07	Merck Patent Gmbh	Isolated organ perfusion combination therapy of cancer
EA201200560A1 (ru) *	2006-01-18	2012-09-28	Мерк Патент Гмбх	Специфическая терапия, использующая интегриновые лиганды для лечения рака
EP2441464B1 (en)	2007-01-18	2014-04-09	Merck Patent GmbH	Integrin ligands for use in treating colon cancer
EP2526967A1 (en)	2007-07-17	2012-11-28	Merck Patent GmbH	Engineered anti-alpha v-integrin hybrid antibodies
WO2010051667A1 (zh) *	2008-11-10	2010-05-14	复旦大学	一种环肽纳米管药物组合物及其应用
MX2011005256A (es) *	2008-11-20	2011-05-31	Merck Patent Gmbh	Nueva terapia y medicamento que usa liganodos de integrina para tratamiento de cancer.
EP2445534A2 (en)	2009-05-25	2012-05-02	Merck Patent GmbH	Continuous administration of cilengitide in cancer treatments
US10087252B2 (en)	2009-07-24	2018-10-02	The Regents Of The University Of California	Methods and compositions for treating and preventing disease associated with αvβ5 integrin
BR112012012862A2 (pt)	2009-12-10	2016-08-16	Merck Patent Gmbh	composição farmacêutica compreendendo oligopeptídeos
EP2593122A1 (en)	2010-07-16	2013-05-22	Merck Patent GmbH	Peptide for use in the treatment of breast cancer and/or bone metastases
WO2012069149A1 (en)	2010-11-23	2012-05-31	Merck Patent Gmbh	Solution comprising cyclic oligopeptides
JP6320042B2 (ja)	2011-02-11	2018-05-09	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	前立腺癌治療のための抗アルファ−ｖインテグリン抗体
WO2012110200A1 (en)	2011-02-18	2012-08-23	Merck Patent Gmbh	Cyclic peptide cyclo (l -arginyl - glycyl - l -aspartyl - d - phenylalanyl - n-methyl - l -valyl), compositions thereof, and use thereof in methods for treating graft -versus - host disease
EP2717854B1 (en) *	2011-06-09	2019-01-16	Merck Patent GmbH	Treatment of cancers and metastases with suspensions of cilengitide in carrier
US20130230485A1 (en) *	2012-03-01	2013-09-05	Kathleen E. Rodgers	Methods for Treating Patients Undergoing Multi-Cycle Chemotherapy
CN103333227B (zh) *	2013-06-07	2015-10-07	东南大学	转移肿瘤缺失蛋白小分子环肽抑制剂及其制备方法与应用
US20190242908A1 (en)	2016-09-08	2019-08-08	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods for diagnosing and treating nephrotic syndrome
JP2019208422A (ja) *	2018-06-04	2019-12-12	コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー	ヒアルロニダーゼを含む新規な組換えエキソソーム及びその用途
GB201911816D0 (en) *	2019-08-16	2019-10-02	Univ London Queen Mary	Treatment
GB202103122D0 (en) *	2021-03-05	2021-04-21	Univ London Queen Mary	Treatment

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04367367A (ja)	1991-06-11	1992-12-18	Nkk Corp	ロータリノズル
RU2116081C1 (ru) *	1992-07-06	1998-07-27	Мерк Патент Гмбх	Циклические ингибиторы адгезии
WO1994008577A1 (en)	1992-10-14	1994-04-28	Merck & Co., Inc.	Fibrinogen receptor antagonists
US5648368A (en)	1992-12-01	1997-07-15	Merck & Co., Inc.	Fibrinogen receptor antagonists
DE4310643A1 (de) *	1993-04-01	1994-10-06	Merck Patent Gmbh	Cyclische Adhäsionsinhibitoren
DE69528829T2 (de)	1994-05-27	2003-08-07	Merck & Co., Inc.	Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
NZ290008A (en)	1994-06-29	1998-08-26	Smithkline Beecham Corp	Vitronectin receptor antagonists, comprising a fibrinogen antagonist analogue linked to a heterocycle
ZA955391B (en)	1994-06-29	1996-02-09	Smithkline Beecham Corp	Vitronectin receptor antagonists
ATE170179T1 (de)	1994-11-02	1998-09-15	Merck Patent Gmbh	Adhäsionsrezeptor-antagonisten
DE19534177A1 (de) *	1995-09-15	1997-03-20	Merck Patent Gmbh	Cyclische Adhäsionsinhibitoren
DE19548709A1 (de) *	1995-12-23	1997-07-03	Merck Patent Gmbh	Tyrosinderivate
JPH09208571A (ja) *	1996-02-02	1997-08-12	Takeda Chem Ind Ltd	アルキリデンシクロヘキサン誘導体
WO1997041844A1 (en)	1996-05-09	1997-11-13	Alcon Laboratories, Inc.	Combinations of angiostatic compounds
US5919815A (en) *	1996-05-22	1999-07-06	Neuromedica, Inc.	Taxane compounds and compositions
ATE470450T1 (de) *	1996-05-31	2010-06-15	Scripps Research Inst	Zusammenstellungen zur verwendung als alpha-v- beta3 vermittelter angiogenesis hemmers
JPH1081631A (ja) *	1996-07-17	1998-03-31	Takeda Chem Ind Ltd	癌転移または再発抑制剤
DE19629817A1 (de)	1996-07-24	1998-01-29	Hoechst Ag	Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19629816A1 (de)	1996-07-24	1998-01-29	Hoechst Ag	Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
UA60311C2 (uk) *	1996-10-02	2003-10-15	Смітклайн Бічам Корпорейшн	Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
WO1998031359A1 (en) *	1997-01-17	1998-07-23	Merck & Co., Inc.	Integrin antagonists
WO1998041844A1 (de) *	1997-03-19	1998-09-24	Heribert Broicher	Verfahren und vorrichtung zur ermittlung eines kennwertes eines stoffes mittels fotolumineszenz
DE19850131A1 (de)	1998-10-30	2000-05-04	Merck Patent Gmbh	Chromenon- und Chromanonderivate

1998
- 1998-09-16 DE DE19842415A patent/DE19842415A1/de not_active Withdrawn
1999
- 1999-09-09 BR BR9913737-2A patent/BR9913737A/pt not_active Application Discontinuation
- 1999-09-09 CZ CZ20010932A patent/CZ302908B6/cs not_active IP Right Cessation
- 1999-09-09 CN CNB998133876A patent/CN1201812C/zh not_active Expired - Fee Related
- 1999-09-09 ES ES04006076T patent/ES2327331T3/es not_active Expired - Lifetime
- 1999-09-09 HU HU0103521A patent/HUP0103521A3/hu unknown
- 1999-09-09 EP EP99969031A patent/EP1113809B1/de not_active Expired - Lifetime
- 1999-09-09 DK DK04006076T patent/DK1466615T3/da active
- 1999-09-09 PT PT04006076T patent/PT1466615E/pt unknown
- 1999-09-09 KR KR1020017003238A patent/KR100703253B1/ko not_active Expired - Fee Related
- 1999-09-09 PL PL348026A patent/PL201902B1/pl not_active IP Right Cessation
- 1999-09-09 WO PCT/EP1999/006654 patent/WO2000015244A2/de not_active Ceased
- 1999-09-09 ID IDW20010746A patent/ID29226A/id unknown
- 1999-09-09 PT PT99969031T patent/PT1113809E/pt unknown
- 1999-09-09 DE DE59911881T patent/DE59911881D1/de not_active Expired - Lifetime
- 1999-09-09 AU AU59758/99A patent/AU765073B2/en not_active Ceased
- 1999-09-09 DK DK99969031T patent/DK1113809T3/da active
- 1999-09-09 US US09/787,374 patent/US6683051B1/en not_active Expired - Lifetime
- 1999-09-09 CN CNB2004100834955A patent/CN100352494C/zh not_active Expired - Fee Related
- 1999-09-09 NZ NZ510040A patent/NZ510040A/en not_active IP Right Cessation
- 1999-09-09 AT AT99969031T patent/ATE292470T1/de active
- 1999-09-09 RU RU2001110104/15A patent/RU2227041C2/ru not_active IP Right Cessation
- 1999-09-09 IL IL14151699A patent/IL141516A0/xx unknown
- 1999-09-09 SK SK337-2001A patent/SK287012B6/sk not_active IP Right Cessation
- 1999-09-09 EP EP04006076A patent/EP1466615B1/de not_active Expired - Lifetime
- 1999-09-09 ES ES99969031T patent/ES2241363T3/es not_active Expired - Lifetime
- 1999-09-09 DE DE59915033T patent/DE59915033D1/de not_active Expired - Lifetime
- 1999-09-09 CA CA002344151A patent/CA2344151A1/en not_active Abandoned
- 1999-09-09 SI SI9930792T patent/SI1113809T1/xx unknown
- 1999-09-09 TR TR2001/00765T patent/TR200100765T2/xx unknown
- 1999-09-09 AT AT04006076T patent/ATE432707T1/de active
- 1999-09-09 JP JP2000569828A patent/JP2002524526A/ja active Pending
- 1999-09-13 MY MYPI99003955A patent/MY129572A/en unknown
- 1999-09-13 PE PE1999000926A patent/PE20001046A1/es not_active Application Discontinuation
- 1999-09-15 AR ARP990104617A patent/AR022382A1/es not_active Application Discontinuation
- 1999-09-16 TW TW088116003A patent/TW576744B/zh not_active IP Right Cessation
- 1999-09-16 CO CO99058733A patent/CO5140070A1/es unknown
2001
- 2001-02-19 IL IL141516A patent/IL141516A/en not_active IP Right Cessation
- 2001-03-15 NO NO20011308A patent/NO331734B1/no not_active IP Right Cessation
- 2001-04-12 ZA ZA200103073A patent/ZA200103073B/en unknown
2010
- 2010-09-15 AR ARP100103356A patent/AR078175A2/es not_active Application Discontinuation
2011
- 2011-08-12 JP JP2011176480A patent/JP2011252012A/ja active Pending

Also Published As

Publication number	Publication date
DE59911881D1 (de)	2005-05-12
SI1113809T1 (en)	2005-10-31
HUP0103521A3 (en)	2002-05-28
NO331734B1 (no)	2012-03-12
IL141516A0 (en)	2002-03-10
PT1466615E (pt)	2009-09-07
NZ510040A (en)	2003-12-19
CN1636590A (zh)	2005-07-13
RU2227041C2 (ru)	2004-04-20
CO5140070A1 (es)	2002-03-22
DE19842415A1 (de)	2000-03-23
CZ2001932A3 (cs)	2001-09-12
KR20010073155A (ko)	2001-07-31
CA2344151A1 (en)	2000-03-23
ES2241363T3 (es)	2005-10-16
CN1329499A (zh)	2002-01-02
EP1466615A1 (de)	2004-10-13
CN100352494C (zh)	2007-12-05
KR100703253B1 (ko)	2007-04-03
ID29226A (id)	2001-08-16
AU5975899A (en)	2000-04-03
DK1466615T3 (da)	2009-08-31
CN1201812C (zh)	2005-05-18
BR9913737A (pt)	2001-06-05
WO2000015244A2 (de)	2000-03-23
PT1113809E (pt)	2005-08-31
PE20001046A1 (es)	2000-10-14
AR022382A1 (es)	2002-09-04
DE59915033D1 (de)	2009-07-16
MY129572A (en)	2007-04-30
CZ302908B6 (cs)	2012-01-18
HUP0103521A2 (hu)	2002-02-28
EP1466615B1 (de)	2009-06-03
IL141516A (en)	2009-09-22
EP1113809A2 (de)	2001-07-11
AU765073B2 (en)	2003-09-11
PL201902B1 (pl)	2009-05-29
NO20011308L (no)	2001-03-15
AR078175A2 (es)	2011-10-19
ATE432707T1 (de)	2009-06-15
EP1113809B1 (de)	2005-04-06
ES2327331T3 (es)	2009-10-28
TW576744B (en)	2004-02-21
PL348026A1 (en)	2002-05-06
ZA200103073B (en)	2002-08-21
ATE292470T1 (de)	2005-04-15
WO2000015244A3 (de)	2000-06-22
SK3372001A3 (en)	2001-11-06
JP2011252012A (ja)	2011-12-15
SK287012B6 (sk)	2009-09-07
JP2002524526A (ja)	2002-08-06
TR200100765T2 (tr)	2001-08-21
US6683051B1 (en)	2004-01-27
DK1113809T3 (da)	2005-08-08

Publication	Publication Date	Title
NO20011308L (no)	2001-03-15	Farmasoytisk preparat som inneholder et syklopeptid og et kjemoterapeutisk middel eller en angiogeneseinhibitor
IS5794A (is)	2000-12-27	Lyfjasamsetning sem inniheldur COX-2-hemil og iNOS-hemil
NO993868D0 (no)	1999-08-11	3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike
DK0814840T3 (da)	2003-02-24	Orale farmaceutiske doseringsformer, der omfatter en protonpumpeinhibitor og et prokinetisk middel
NO20011157D0 (no)	2001-03-07	Benzenderivater og farmasøytisk anvendelse derav
NO20021401D0 (no)	2002-03-20	Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO984107L (no)	1998-11-09	Kappa-agonist-forbindelser og farmas°ytiske preparater derav
NL1016224A1 (nl)	2001-03-22	Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
NO20003254D0 (no)	2000-06-22	Anti-østrogene steroider og farmasøytisk preparat inneholdende samme, samt anvendelse derav
NO20001914D0 (no)	2000-04-12	<alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
NO995784L (no)	2000-05-29	Fytosterol og/eller fytosterolderivater
NO20013883D0 (no)	2001-08-09	Frysetorket middel inneholdende paramylon, samt fremgangsmate og anvendelse derav
DK0813873T3 (da)	2002-05-27	Farmaceutisk sammensætning omfattende mirtazapin og en eller flere selektive serotingenoptagelseshæmmere
NO20011950L (no)	2001-06-25	Farmasöytiske blandinger som inneholder poly(ADP-ribose) glukohydrolaseinhibitorer og fremgangsmåter for anvendelse avsamme
NO991407D0 (no)	1999-03-23	Legemiddelaerosolformuleringer som omfatter budesonid
NO993467D0 (no)	1999-07-14	Granuler som innbefatter klavulanat og en eller flere eksipienter
NO20030759D0 (no)	2003-02-18	10-aryl-11-HBENZO(b)fluorenderivater og analoger for medisinsk anvendelse
PT1237856E (pt)	2004-08-31	Novos derivados fenilicos tri-substituidos e analogos
NO306114B1 (no)	1999-09-20	Substituerte 4-fenyltiazolderivater og farmasöytiske blandinger som inneholder dem
DK0643922T3 (da)	2001-01-02	Aromatiserende middel
NO992998L (no)	1999-08-18	Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
NO20004904L (no)	2000-11-29	C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som medikamenter
DE69926012D1 (de)	2005-08-04	Arzneizubereitungen
NO20003142L (no)	2000-06-16	Substituerte isokinolin-derivater og anvendelse derav som antikrampemidler
NO20006626D0 (no)	2000-12-22	Beleggingsmiddel og anvendelse herav

Legal Events

Date	Code	Title	Description
2011-05-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application
2014-04-28	MM1K	Lapsed by not paying the annual fees